Macquarie raises concerns about PhonePe’s ESOP costs and revenue concentration ahead of its IPO. High ESOP expenses impact EBITDA margins, and regulatory changes could reduce revenues by 20-25%. PhonePe’s upcoming IPO includes an offer-for-sale of shares.